Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

This study has been completed.
Sponsor:
Collaborator:
UNC Lineberger Comprehensive Cancer Center
Information provided by (Responsible Party):
Sanofi
ClinicalTrials.gov Identifier:
NCT01173497
First received: July 28, 2010
Last updated: October 21, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2013
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)